Loading…
pharmacygeoff.md sold unapproved new drugs and misbranded drug products through its website, including products claiming to treat, prevent, or cure COVID-19, lupus, rheumatoid arthritis, malaria, HIV, and hepatitis C, in violation of sections 505(a) and 502 of the Federal Food, Drug, and Cosmetic Act. The company failed to obtain FDA approval or authorization before marketing these drugs to U.S. consumers over the internet. The FDA issued this warning during the declared national emergency for COVID-19, emphasizing that unapproved drugs lack the safety and effectiveness assurances of FDA-regulated products.